Illustration: Tiffany Herring/Axios
EQT is considering selling a part of its stake in WS Audiology, valuing the global hearing aid maker at about $7.8 billion, Bloomberg reports.
Why it matters: In 2022, the FDA approved the sale of hearing aids over the counter — a major change that broadened access significantly.
